AAAAAA
Results:
1-19
|
Results: 19
Authors:
Ardizzoni, A
Citation: A. Ardizzoni, Osteocyte lacunar size-lamellar thickness relationships in human secondaryosteons, BONE, 28(2), 2001, pp. 215-219
Authors:
Grossi, F
Scolaro, T
Tixi, L
Loprevite, M
Ardizzoni, A
Citation: F. Grossi et al., The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer, CR R ONC H, 37(1), 2001, pp. 61-67
Authors:
Tjan-Heijnen, VCG
Postmus, PE
Ardizzoni, A
Manegold, C
Burghouts, J
van Meerbeeck, J
Gans, S
Mollers, M
Buchholz, E
Biesma, B
Legrand, C
Debruyne, C
Giaccone, G
Citation: Vcg. Tjan-heijnen et al., Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study, ANN ONCOL, 12(10), 2001, pp. 1359-1368
Authors:
Scolaro, T
Bacigalupo, A
Ardizzoni, A
Tixi, L
Cafferata, M
Grossi, F
Rosso, R
Vitale, V
Citation: T. Scolaro et al., Acute effects in patients with inoperable NSCLC treated by a regimen of induction chemotherapy (CT) followed by radiotherapy (RT) and concurrent CT, TUMORI, 87(4), 2001, pp. S125-S125
Authors:
Loprevite, M
Favoni, RE
de Cupis, A
Pirani, P
Pietra, G
Bruno, S
Grossi, F
Scolaro, T
Ardizzoni, A
Citation: M. Loprevite et al., Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines, LUNG CANC, 33(1), 2001, pp. 27-39
Authors:
Castagneto, B
Zai, S
Mutti, L
Lazzaro, A
Ridolfi, R
Piccolini, E
Ardizzoni, A
Fumagalli, L
Valsuani, G
Botta, M
Citation: B. Castagneto et al., Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion - Results of a phase II study on 31 consecutive patients, LUNG CANC, 31(2-3), 2001, pp. 303-310
Authors:
Ardizzoni, A
Cafferata, MA
Paganuzzi, M
Filiberti, R
Marroni, P
Neri, M
Fontana, V
Nicolo, G
Perdelli, L
Stampino, CG
Rosso, R
Puntoni, R
Citation: A. Ardizzoni et al., Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma, CANCER, 92(7), 2001, pp. 1896-1904
Authors:
Parra, HS
Tixi, L
Latteri, F
Bretti, S
Alloisio, M
Gravina, A
Lionetto, R
Bruzzi, P
Dani, C
Rosso, R
Cosso, M
Balzarini, L
Santoro, A
Ardizzoni, A
Citation: Hs. Parra et al., Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in thetreatment of advanced malignant pleural mesothelioma - A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP), CANCER, 92(3), 2001, pp. 650-656
Authors:
Ardizzoni, A
Grossi, F
Salvati, F
Silvano, G
Santi, L
Citation: A. Ardizzoni et al., Managing patients with lung cancer - Common international guidelines must be developed, BR MED J, 320(7231), 2000, pp. 380-380
Authors:
Ardizzoni, A
Grossi, F
Citation: A. Ardizzoni et F. Grossi, Update on the treatment of small cell lung cancer (SCLC), ANN ONCOL, 11, 2000, pp. 101-108
Authors:
Ardizzoni, A
Antonelli, G
Ricci, S
Frasci, G
Rinaldi, M
Boni, L
Galletti, P
Pennucci, MC
Antonuzzo, A
Gravina, A
Galli, L
Comella, G
Conte, PF
Salvati, F
Rosso, R
Citation: A. Ardizzoni et al., Ambamustine in the second-line treatment of patients with small-cell lung cancer - A phase II Fonicap study, AM J CL ONC, 23(1), 2000, pp. 22-25
Authors:
Ardizzoni, A
Grossi, F
Meazza, R
Ferrini, S
Citation: A. Ardizzoni et al., New perspectives for the pharmacological and biological therapy of small cell lung cancer, CR R ONC H, 31(2), 1999, pp. 135-145
Authors:
Loprevite, M
Favoni, RE
de Cupis, A
Pirani, P
Merlo, F
Grossi, F
Ardizzoni, A
Citation: M. Loprevite et al., Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity, INT J ONCOL, 15(4), 1999, pp. 787-792
Authors:
Ardizzoni, A
Antonelli, G
Grossi, F
Tixi, L
Cafferata, M
Rosso, R
Citation: A. Ardizzoni et al., The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC), ANN ONCOL, 10, 1999, pp. 13-17
Authors:
Orengo, AM
Procopio, A
Favoni, RE
De Cupis, A
Ardizzoni, A
Castagneto, B
Ribotta, M
Detta, PG
Ferrini, S
Mutti, L
Citation: Am. Orengo et al., Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis, EUR RESP J, 13(3), 1999, pp. 527-534
Authors:
De Marinis, F
Rinaldi, M
Ardizzoni, A
Bruzzi, P
Pennucci, MC
Portalone, L
D'Aprile, M
Ripanti, P
Romano, F
Belli, M
Altavilla, G
Migliorino, MR
Rosso, R
Salvati, F
Citation: F. De Marinis et al., The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: A phase III randomized FONICAP trial, TUMORI, 85(3), 1999, pp. 177-182
Authors:
van Meerbeeck, JP
Bass, P
Debruyne, C
Groen, HJ
Manegold, C
Ardizzoni, A
Gridelli, C
van Marck, EA
Lentz, M
Giaccone, G
Citation: Jp. Van Meerbeeck et al., A phase II study of gemcitabine in patients with malignant pleural mesothelioma, CANCER, 85(12), 1999, pp. 2577-2582
Authors:
Ardizzoni, A
Grossi, F
Scolaro, T
Giudici, S
Foppiano, F
Boni, L
Tixi, L
Cosso, M
Mereu, C
Ratto, GB
Vitale, V
Rosso, R
Citation: A. Ardizzoni et al., Induction chemotherapy followed by concurrent standard radiotherapy and daily low dose cisplatin in locally advanced non-small-cell lung cancer, BR J CANC, 81(2), 1999, pp. 310-315
Authors:
Ardizzoni, A
Cafferata, MA
Rosso, R
Citation: A. Ardizzoni et al., Epoetin-alpha in lung tumors, TUMORI, 84(6), 1998, pp. S20-S26
Risultati:
1-19
|